Načítá se...
Therapeutic Aptamers: Evolving to Find their Clinical Niche
BACKGROUND: The discovery that short oligonucleotides, termed aptamers, can fold into three-dimensional structures that allow them to selectively bind and inhibit the activity of pathogenic proteins is now over 25 years old. The invention of the SELEX methodology heralded in an era in which such nuc...
Uloženo v:
| Vydáno v: | Curr Med Chem |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8177732/ https://ncbi.nlm.nih.gov/pubmed/31573879 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/0929867326666191001125101 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|